NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT04307147 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

316

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Vinorelbine

Sponsor

Fudan University